Correlation Between Freeline Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freeline Therapeutics Holdings and Eliem Therapeutics, you can compare the effects of market volatilities on Freeline Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Freeline Therapeutics and Eliem Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Freeline and Eliem is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Freeline Therapeutics and Eliem Therapeutics
If you would invest 431.00 in Freeline Therapeutics Holdings on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Freeline Therapeutics Holdings or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.72% |
Values | Daily Returns |
Freeline Therapeutics Holdings vs. Eliem Therapeutics
Performance |
Timeline |
Freeline Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eliem Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Freeline Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Freeline Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Freeline Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.Freeline Therapeutics vs. Cns Pharmaceuticals | ||
Freeline Therapeutics vs. ZyVersa Therapeutics | ||
Freeline Therapeutics vs. Immix Biopharma | ||
Freeline Therapeutics vs. Hepion Pharmaceuticals |
Eliem Therapeutics vs. Pmv Pharmaceuticals | ||
Eliem Therapeutics vs. MediciNova | ||
Eliem Therapeutics vs. Pharvaris BV | ||
Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |